ResMed (RMD) Competitors

ResMed (NYSE:RMD) and Medtronic (NYSE:MDT) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk.

Which has more volatility & risk, RMD or MDT?

ResMed has a beta of 0.7, suggesting that its stock price is 30% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500.

Is RMD or MDT more profitable?

ResMed has a net margin of 25.34% compared to Medtronic's net margin of 13.00%. ResMed's return on equity of 26.17% beat Medtronic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ResMed	25.34%	26.17%	18.60%
Medtronic	13.00%	13.79%	7.62%

Does the media favor RMD or MDT?

In the previous week, Medtronic had 10 more articles in the media than ResMed. MarketBeat recorded 52 mentions for Medtronic and 42 mentions for ResMed. Medtronic's average media sentiment score of 1.20 beat ResMed's score of 0.77 indicating that Medtronic is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ResMed	20 Very Positive mention(s)	5 Positive mention(s)	8 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Medtronic	42 Very Positive mention(s)	1 Positive mention(s)	9 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Does the MarketBeat Community prefer RMD or MDT?

Medtronic received 1158 more outperform votes than ResMed when rated by MarketBeat users. Likewise, 75.61% of users gave Medtronic an outperform vote while only 52.70% of users gave ResMed an outperform vote.

Company	Underperform	Outperform
ResMed	Outperform Votes 429 52.70%	Underperform Votes 385 47.30%
Medtronic	Outperform Votes 1587 75.61%	Underperform Votes 512 24.39%

Do institutionals & insiders hold more shares of RMD or MDT?

55.0% of ResMed shares are held by institutional investors. Comparatively, 82.1% of Medtronic shares are held by institutional investors. 0.7% of ResMed shares are held by insiders. Comparatively, 0.2% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Is RMD or MDT a better dividend stock?

ResMed pays an annual dividend of $2.12 per share and has a dividend yield of 0.9%. Medtronic pays an annual dividend of $2.80 per share and has a dividend yield of 3.1%. ResMed pays out 25.0% of its earnings in the form of a dividend. Medtronic pays out 85.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. ResMed has increased its dividend for 12 consecutive years and Medtronic has increased its dividend for 35 consecutive years. Medtronic is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Do analysts prefer RMD or MDT?

ResMed currently has a consensus price target of $244.73, suggesting a potential upside of 3.33%. Medtronic has a consensus price target of $95.00, suggesting a potential upside of 5.54%. Given Medtronic's higher probable upside, analysts clearly believe Medtronic is more favorable than ResMed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ResMed	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.60
Medtronic	1 Sell rating(s)	9 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.41

Which has higher valuation and earnings, RMD or MDT?

Medtronic has higher revenue and earnings than ResMed. Medtronic is trading at a lower price-to-earnings ratio than ResMed, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ResMed	$4.69B	7.42	$1.02B	$8.47	27.96
Medtronic	$32.36B	3.57	$3.68B	$3.27	27.53

Summary

Medtronic beats ResMed on 11 of the 21 factors compared between the two stocks.